Results

Total Results: 1,161 records

Showing results for "patient safety".

261. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - ) what patient, surgical or postsurgical characteristics predict or differentiate patient risk of venous … Safety surveillance alerts: No safety alert was identified. … Safety surveillance alerts: No safety alert was identified. … Safety surveillance alerts: No safety alert was identified. … Safety surveillance alerts: No safety alert was identified.

262. Chicago-Area DEcIDE Center (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
     May 01, 2009 - The DEcIDE network assists health care providers, patients, and policymakers seeking unbiased information … Notably, while raising some concerns about off-label use, the studies also identify disease- and patient-specific … Three prior studies have examined off-label use among broader, more representative patient populations … insure that the most common drugs dispensed through pharmacies matched those reported by physicians at patient … Regulatory and reimbursement issues in treating patients with immune-mediated neuropathies.

263. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - According to the Cystic Fibrosis Foundation’s 2014 patient registry, almost 47% of CF patients in the … One phase III trial is ongoing, evaluating pirfenidone’s long-term safety and efficacy in patients … However, experts thought that patients are likely to accept lumacaftor/ivacaftor if long-term safety … Safety and efficacy of treatment with lumacaftor in combination with ivacaftor in patients with CF … Safety and tolerability of nintedanib in patients with Ipf: interim analysis from an open-label extension

264. Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/anxiety-children_research-protocol.pdf
     September 12, 2016 - There is a great deal of uncertainty regarding comparative effectiveness and safety of all treatments … that are widely available and validated; which are:(patients/parent reported and clinician assessed … What are the treatment burdens (for patients, providers, and health systems) and contextual factors … specific phobias, generalized • Animals • Adults (age >= 18 years) • Infants (age < 3 years) • Patients … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing

265. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
     January 01, 2010 - of trauma experienced (including acute vs. chronic types of PTSD), timing of treatment initiation, patient … What patient characteristics (including those listed below) are associated with variations in treatment … Is there sufficient evidence to support treatment matching based on patient characteristics or resources … Indirect/media (location at time of exposure—degree of safety) 3. … Does this vary by age, sex, or other patient characteristics?

266. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic … Diabetes and gout: efficacy and safety of febuxostat and allopurinol. … The efficacy and safety of febuxostat for urate lowering in gout patients >/=65 years of age. … African American patients with gout: efficacy and safety of febuxostat vs allopurinol. … Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.

267. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - thrombosis (ST)], and two relating to both safety and effectiveness [composite of death, MI, ST, … The safety-only definition of MACE yielded a hazard ratio of 1.75 (p<0.05), indicating that patients … definitions also yielded different results; while the safety- only composite endpoint demonstrated … This construct comprises outcomes from the patient perspective and are measured by asking the patient … using clozapine may appear to have a worse safety profile with respect to this outcome.

268. ECRI_Penn EPC FINAL Environ Cleaning Protocol 08_21_14 CC[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/healthcare-infections_research-protocol.pdf
     January 01, 2014 - What criteria (clinical effectiveness, safety, adherence to FDA regulations, market value, others) … of patients (family/guests)? … Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), Occupational Safety … searched to identify clinical practice guidelines, white papers or position statements, regulatory or safety … OR "patient rooms" OR "patients rooms" OR "health care setting" OR "health care settings" OR ward OR

269. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hip-fracture-pain.ppt
     May 01, 2011 - effectiveness and safety? … Evidence about the patient subpopulation characteristics that influence effectiveness and safety was … It is important to note that no studies examined the effectiveness or safety of the most commonly used … The evidence may support continued research to test effectiveness and safety. … Influence of Subpopulation Characteristics on Effectiveness and Safety (2) Abou-Setta AM, Beaupre LA,

270. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain.ppt
     May 01, 2011 - effectiveness and safety? … Evidence about the patient subpopulation characteristics that influence effectiveness and safety was … It is important to note that no studies examined the effectiveness or safety of the most commonly used … The evidence may support continued research to test effectiveness and safety. … Influence of Subpopulation Characteristics on Effectiveness and Safety (2) Abou-Setta AM, Beaupre LA,

271. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Summary of available data on patient characteristics and response to prior medical treatment have been … The subjective parameters should also include Patient Reported Outcomes (PROs) as appropriate instruments … At baseline and Week 4 (Final Visit), 3 patient-reported outcome questionnaires were completed to assess … comprising 11% of patients in the trials.1 No overall differences were seen in the safety or effectiveness … The safety of Thank you for your comments.

272. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - IL-1 may be a problematic target with respect to safety in the gout patient population, however, and … and tolerability due to safety concerns over infections reported in trials thus far. … These safety concerns may present barriers to approval or barriers to diffusion if approved. … These safety concerns may present significant barriers to approval and diffusion if approved. … SLE: belimumab safety, efficacy sustained over 6 years. [internet].

273. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
     August 13, 2012 - end-users and facilitates appropriate translation of the results into health care practice and use by patient … If the FDA approves, human testing for safety and efficacy can begin. … These endpoints may be categorized as clinical endpoints, patient-reported outcomes and quality of … On the other hand, a patient who has a health condition where there are few treatments may be willing … Likewise, some patient groups were reported to be concerned by the decision since it presumably would

274. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - Patients and their diabetes care teams work to adjust patient insulin dosages using feedback from a … health outcomes, citing safety concerns and limited efficacy data. … Summary of safety and effectiveness data (SSED). MiniMed 530G system. P120010. … Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients … A study of the safety and efficacy of a new treatment for diabetic macular edema.

275. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Preliminary data for these interventions are promising, and ongoing trials are clarifying the safety … Results and Discussion of Comments Seven experts, with clinical, research, patient safety, and health … widespread, if data support its efficacy and safety, the experts thought. … Investigators reported high patient adherence (81% and 94%; adherence defined as patients completing … that SPARX could positively affect patient health outcomes by providing an alternative for patients

276. AHRQ’s Evidence-based Practice Center Program: Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
     November 01, 2022 - models of care (e.g., impact of telehealth on health outcomes, mobile health technology for diabetes, patient … safety in ambulatory settings).

277. Asthma-Immunotherapy-2010 Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
     January 01, 2010 - With continued administration, it is expected that the treatment regimen will make the patient tolerant … KQ 2 What is the evidence for safety of SIT in patients with allergic rhinoconjunctivitis and/or … Safety of long-acting beta2-agonists in the treatment of asthma. … Not all patients with asthma are allergic. … The activity domain contains 5 ‘patient-specific’ questions.

278. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - • There are no safety concerns Summary Decision: This CER’s priority for updating is Low … UUI in 40% patients on 150 U; p=0.022 • >75% improvement versus baseline in UUI in 40% patients on 100 … UUI in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on … The  efficacy  and  safety  of  solifenacin   in  patients  with  overactive  bladder … in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on 100

279. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - significantly increased the regulatory bar for gaining approval—specifically regarding preapproval safety … data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, potential increase in per- patient costs might serve as barriers to acceptance by some patients … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.

280. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - For this reason, it is also important to capture long-term safety to obtain a global aspect of how … these therapies impact patient care, both benefits and harms. … For KQ 1, what does this patient population look like? … Efficacy and safety of infliximab vs. … One patient was reported to have hypertension in patients who switched from methotrexate to infliximab